lundi 3 juillet 2017

Onco Actu du 3 juillet 2017

1. Biologie

How to Know When a New Target is Really a New Target [In the Pipeline]

3.1 Tabac

British smokers down by 1.9million since the ban [Cancer Research UK]

The UK is 10 years smoke-free and there’s more at stake than just clean-smelling clothes [Cancer Research UK]

4.7 Dép., diag. & prono. - Col de l'utérus

More than a quarter of women missing smear tests are unaware they exist [Cancer Research UK]

Some women in the UK still unaware of cervical screening [NHS Choices]

5. Traitements

Extensive Lymph Node Surgery Does Not Increase Survival in Melanoma [NCI]

5.12 Immunothérapies

Beyond the Cycle [Genentech]

5.2.1 Pharma - Partenariats

Big pharma turns to AI to speed drug discovery, GSK signs deal [Reuters]

5.3.4 Traitements - AMM (FDA, EMA)

BESPONSA® Approved in the EU for Adult Patients with Relapsed or Refractory B-cell Precursor Acute Lymphoblastic Leukemia [Pfizer]

5.4 Traitements - Economie

High Drug Prices Are Bad. Cutting Them Could Be Worse. [NY Times]

Popular Cancer Pill Goes Generic, Yet Patients’ Costs Stay High [Bloomberg]

5.6 ESMO

World GI 2017 Press Release: Right-sided Colorectal Tumours: An Internal Radiation Advantage [ESMO]

5.9 AACR

Turning the Tide Against Cancer 2017 National Conference Brings the Patient Voice to Oncology Policy, Research, and Care [AACR]

6. Lutte contre les cancers

MD Anderson announces new leadership structure [MD Anderson]

6.1 Observation

Thousands of cancer patients dying in needless agony, new data reveals [The Telegraph]

Large health inequalities across England revealed [Cancer Research UK]

6.11 Patients

The Best-Positioned Tech Giant In Healthcare? The Answer Might Surprise You. [Forbes]

Cancer patients should check drug list with pharmacist [Reuters]

6.12 Ethique

Porous Boundaries [JAMA]

6.7.1 Bioinformatique

What’s the Business Model for Artificial Intelligence in Healthcare? [Xconomy]

Is IBM Watson A 'Joke'? [Forbes]

6.9 Controverses

Who’s paying for lunch? Here’s exactly how drug companies wine and dine our doctor [The Conversation]

Is There A Better Place To Decide What's Right For Patients? [Forbes]